fbpx
Medical Innovation Exchange

‘A negative trial, not a failed trial’: Neurocrine axes in-licensed tremor program on phase 2 data

https://www.fiercebiotech.com/biotech/it-was-not-failed-trial-it-was-negative-trial-neurocrine-axes-licensed-essential-tremor

Leave a Comment

Your email address will not be published.

Leave the field below empty!

This site uses Akismet to reduce spam. Learn how your comment data is processed.